Skip to content

TO COMPARE ATRACURIUM AND CISATRACURIUM IN PATIENTS UNDERGOING SURGERIES UNDER GENERAL ANAESTHESIA

COMPARISON OF ATRACURIUM AND CISATRACURIUM WITH REGARDS TO THEIR POTENCY, ONSET TIME OF NEUROMUSCULAR BLOCKADE AND RECOVERY IN PATIENTS UNDERGOING SURGERIES UNDER GENERAL ANAESTHESIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036426
Enrollment
60
Registered
2021-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: Intravenous Atracurium: Intravenous Atracurium 0.5mg/kg loading dose followed by 0.15mg/kg maintenance with regards to potency, onset time of neuromuscular blockade and recovery

Sponsors

Dheeraj Gopal Ravindran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I or II fit patients. 2. Patients aged between 18 and 60 years of age. 3. Patients undergoing surgeries under general anaesthesia. 4. Haemodynamically stable patients with all routine investigations within normal limits and without any comorbidities. 5. Written informed consent from the concerned patient.

Exclusion criteria

Exclusion criteria: 1. Patients who are not willing to participate in the study. 2. Patients with ASA grade III and above physical status. 3. Patients who are aged less than 18 and more than 60 years of age. 4. Patients who are posted for emergency procedures. 5. Patients with known allergy to the study drugs. 6. Patients with difficult intubation. 7. Patients who are obese. 8. Patients who have psychiatric, neurological, neuromuscular or cardiovascular disease or impairment of hepatic or renal function.

Design outcomes

Primary

MeasureTime frame
1. To compare onset time for intubation. 2. To observe intubating conditions. 3. To compare duration of neuromuscular blockade.Timepoint: Time taken from administration of study drug to intubation in seconds and the duration of neuromuscular blockade in minutes

Secondary

MeasureTime frame
1. To observe hemodynamic effects of both drugs. 2. To observe any side effects.Timepoint: Hemodynamic parameters recorded before induction, after giving study drug, at the time of intubation and at 1, 2, 3, 5, 10 and 15 min after intubation

Countries

India

Contacts

Public ContactDheeraj Gopal Ravindran

Dr. D. Y. Patil Medical College, Hospital & Research Centre

chhayasuryawanshi@gmail.com9922888201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026